What's in the vial. Where it comes from. How it's tested by an FDA-registered lab. Why no competitor matches it. Every question about buying stem cells for your practice — answered with independent lab data, documented traceability, and plain-language science.
MSCs, exosomes, Wharton's Jelly, growth factors — doctors ask us about these every time they consider buying stem cells for their practice. Here's what each component is, why it matters clinically, and why APEX delivers all of them together in a single product unlike any other stem cell supplier.
The gelatinous connective tissue surrounding the blood vessels inside the umbilical cord. It is nature's most concentrated depot of regenerative material — rich in MSCs, exosomes, growth factors, hyaluronic acid, and collagen, all present in their native environment together. When APEX processes umbilical cord tissue, this is where everything comes from.
The actual living cells. MSCs can differentiate into bone, cartilage, muscle, and fat tissue — and they actively signal surrounding cells to reduce inflammation and initiate repair. Think of them as the construction crew: they assess the damage and direct the rebuilding. Their potency comes from being pluripotent — capable of becoming many different cell types depending on what the body needs.
Nano-sized vesicles that stem cells release as their communication system. They carry proteins, RNA, and signaling molecules that instruct nearby cells to heal, divide, or reduce inflammation — without being living cells themselves. They're more stable than MSCs and travel easily through tissue. APEX products contain both MSCs and their exosomes — the full signal plus the source. Our exosome count of 3.65 × 10¹¹ particles/mL is independently verified by Nanoparticle Tracking Analysis.
Proteins that act like specific commands delivered to cells — "form collagen here," "grow blood vessels here," "stop inflammation here." Key factors include VEGF (angiogenesis), TGF-β (tissue repair), PDGF-BB (regeneration), and EGF (epithelial growth). They are the mechanism by which MSCs and exosomes produce results. APEX quantifies 6 key growth factors per lot — the data is published, not just claimed.
A naturally occurring sugar molecule that holds up to 1,000× its weight in water. In joints, it provides cushioning and lubrication. In tissue, it creates a hydrated environment where cell repair can occur. In skincare, it's the active ingredient behind most premium moisturizing treatments. In APEX products, it's not an additive — it's native to the Wharton's Jelly matrix, exactly as the body uses it. Particularly valuable in orthopedic and joint applications.
Small proteins that regulate the immune response and control inflammation. Anti-inflammatory cytokines (like IL-10 and IL-4) calm overactive immune reactions — critical in arthritis, autoimmune disorders, and post-surgical recovery. Together with growth factors, they form the complete communication network that makes regenerative therapy work. The difference between a product with the full cytokine matrix versus an isolated extract is measurable in clinical outcomes.
"Our product comes from umbilical cord Wharton's Jelly — nature's most concentrated source of regenerative material. Inside it you get live stem cells, the exosomes they release, growth factors, hyaluronic acid, and cytokines — all working together the way they do in the body. Competitors sell you one piece of that puzzle. APEX delivers the whole system."— APEX Stem Cells · apexstemcells.com
When you buy stem cells from APEX, you're buying full traceability. A strict 7-step protocol governs every vial — from a screened, consenting U.S. donor to your IV line. No mystery. No shortcuts. Documentation at every stage.
A healthy pregnant mother voluntarily enrolls in a birth tissue donation program and provides informed written consent to donate her placenta and umbilical cord after delivery. This is entirely altruistic — no compensation is provided to the donor.
✦ 100% voluntary donationComprehensive medical screening — only a small percentage of applicants qualify. Key disqualifying factors:
The baby is delivered via planned Cesarean section in a sterile hospital environment. This controlled method ensures the placenta and umbilical cord are collected under optimal conditions with minimal contamination risk. The mother and baby are entirely unaffected by the collection process.
🏥 Sterile, controlled environmentImmediately after delivery, the placenta and umbilical cord are collected by trained personnel under sterile conditions and placed into a controlled cold environment. Temperature and time are logged throughout — the cold chain documentation begins at this exact moment.
❄️ Cold chain documentation begins hereInside a certified cGMP lab, mesenchymal stem cells are extracted from Wharton's Jelly — the gelatinous connective tissue inside the umbilical cord, uniquely rich in regenerative cells. For APEX IV, the cells are concentrated 4× for maximum therapeutic potency — the highest yield available from any birth tissue source.
🧬 4× concentrated for APEX™ IV ✦ Highest MSC yield of any birth tissueBefore any product is released, it's independently tested by Eurofins DPT (CLIA-certified) and Ohio University Innovation Center. Nothing ships until every test passes:
Approved vials are filled, cryogenically frozen at −80°C, sealed in insulated cryo packaging, and shipped directly to your practice. When the box arrives, the signed Certificate of Analysis is placed right on top of the packaging — printed, signed by the lab director, ready to verify before you touch a single vial.
Our FDA-registered manufacturing facility (FEI #3027285830) in Florida produces every lot. Every lot is independently tested by Eurofins DPT and Ohio University Innovation Center before it ships. This is the most rigorously verified stem cell lab data available from any B2B supplier.
Two independent institutions. 14 safety tests. Full growth factor quantification. Published per lot.
APEX products are manufactured at a fully FDA-registered biological tissue facility located in Florida. The facility operates under FDA Establishment Registration with FEI Number 3027285830, confirming compliance with 21 CFR Part 1271 requirements for human cells, tissues, and cellular and tissue-based products (HCT/Ps). This registration is verifiable directly through the FDA's database.
Every batch screened for 13 communicable diseases and undergoes 14-day sterility and endotoxin testing before approval. Testing by Eurofins DPT (CLIA ID: 06D0717586).
| Test | Result | Status |
|---|---|---|
| Chagas (EIA) | Non-Reactive | Pass |
| CMV IgM | Negative | Pass |
| Hepatitis B Core Total Ab | Non-Reactive | Pass |
| Hepatitis B Surface Ag | Non-Reactive | Pass |
| Hepatitis C Virus Ab | Non-Reactive | Pass |
| HIV Ag/Ab Combo | Non-Reactive | Pass |
| HTLV I/II Ab | Non-Reactive | Pass |
| Syphilis Screening | Non-Reactive | Pass |
| Ultrio Elite HBV | Non-Reactive | Pass |
| Ultrio Elite HCV | Non-Reactive | Pass |
| Ultrio Elite HIV-1/2 | Non-Reactive | Pass |
| West Nile Virus (WNV) | Non-Reactive | Pass |
| 14-Day Sterility (USP <71>) | No Growth — Day 14 | Pass |
| Endotoxin (ENDOSAFE PTS150) | <0.100 EU/mL | Pass |
Communicable disease and sterility testing by Eurofins DPT, CLIA ID 06D0717586, Centennial, CO. Lot 20A0032 met all eligibility and testing requirements per FDA 21 CFR Part 1271.
Tested by Nanoparticle Tracking Analysis (NTA) at Ohio University Innovation Center to verify particle concentration and size — confirming therapeutic dose and optimal delivery range.
| Test | Specification | Result | Status |
|---|---|---|---|
| Particle Concentration (particles/mL) — NTA | ≥ 3.5 × 10¹¹ | 3.65 × 10¹¹ ± 1.18 × 10¹⁰ | Approved |
| Mean Particle Diameter — NTA | 30 – 150 nm | 128.3 ± 3.9 nm | Approved |
| Mode Particle Diameter — NTA | 30 – 150 nm | 95.3 ± 4.3 nm | Approved |
| Sterility (Direct Method, USP <71>) | No Growth | No Growth | Approved |
| Endotoxin (Kinetic Chromogenic LAL, USP <85>) | < 2.5 EU/mL | < 0.05 EU/mL (Spike Recovery: 108%) | Approved |
Sterile filtered (0.2 µm). QC testing conducted in compliance with cGMP standards. — Comprehensive Biosciences / Ohio University Research Partner.
Independent testing by Ohio University Innovation Center measures the actual biological activity inside every 1 mL vial of WJ+. These are the specific proteins responsible for regenerative effects — quantified, not estimated. Report date: February 17, 2026.
Growth factor concentrations measured at Ohio University Innovation Center, 340 W State St, Athens, OH 45701. Date of Report: February 17, 2026. All concentrations based on a 1 mL sample of WJ+ from Comprehensive Biosciences.
Most suppliers tell you their product is good.
We prove it.
| Verification Standard | APEX™ | Platinum Biologics | Vitti Labs | Blue Sky Biolabs |
|---|---|---|---|---|
| Third-party CLIA-certified lab testing | ✓ Eurofins DPT | Varies by lot | Internal + 3rd party | 3rd party listed |
| Full 13-panel communicable disease screening | ✓ All 13 published | Standard panels | Standard panels | Not fully published |
| 14-day sterility testing (USP <71>) | ✓ No Growth — Day 14 | ✓ | ✓ | ✓ |
| Endotoxin testing with spike recovery validation | ✓ <0.05 EU/mL (108% recovery) | Tested, not always published | Tested | Tested |
| NTA particle count publicly published | ✓ 3.65×10¹¹/mL | Concentration stated | NTA performed | ✗ Not published |
| Published growth factor profile (pg/mL per lot) | ✓ 6 factors quantified | ✗ Not public | Partial panel | ✗ Not published |
| FDA-registered manufacturing facility | ✓ FEI #3027285830 | ✓ | ✓ | ✓ |
| University research partner for independent validation | ✓ Ohio University Innovation Center | ✗ | ✗ | ✗ |
| Per-lot CoA with full published data tables | ✓ Full report public | Available on request | Available on request | Available on request |
| Turnkey partner system (training + marketing + protocols) | ✓ Full system included | ✗ Product only | ✗ Product only | ✗ Product only |
| Operated by a practicing clinical team | ✓ Proven in own clinic | ✗ | ✗ | ✗ |
Competitor information based on publicly available website content as of early 2026. APEX makes no claim that competitors are non-compliant — only that APEX sets a higher standard of proactive transparency.
Every APEX lot must satisfy all six compliance pillars before it reaches a partner clinic. These are the standards that make APEX the safest and most defensible stem cell product you can buy for your practice.
The most common questions doctors, med spa owners, and clinic operators ask before partnering with APEX — answered directly.
Yes. APEX Stem Cells is a B2B supplier of umbilical cord-derived mesenchymal stem cells (MSCs) and exosomes exclusively to licensed medical practices — including IV clinics, med spas, functional medicine doctors, and chiropractors. Products are regulated under FDA 21 CFR Part 1271 as HCT/P tissues. To order, practices complete an APEX Elite Provider Agreement and verification of licensure. Start the process here.
Yes. APEX products are manufactured at an FDA-registered HCT/P establishment located in Florida, holding FDA Establishment Registration FEI Number 3027285830 under 21 CFR Part 1271. FDA registration confirms the facility's compliance for human cells, tissues, and cellular and tissue-based products (HCT/Ps). This is verifiable directly in the FDA's establishment registration database at accessdata.fda.gov.
Umbilical cord Wharton's Jelly is widely considered the superior source for clinical use. Compared to bone marrow or adipose-derived MSCs, Wharton's Jelly MSCs are younger, more potent, have a higher proliferative capacity, and require no invasive harvesting procedure from the patient. APEX products deliver the complete Wharton's Jelly matrix — live MSCs, exosomes, growth factors, hyaluronic acid, and cytokines — not isolated fragments.
Every APEX lot undergoes: (1) 13-panel communicable disease screening including HIV, Hepatitis B & C, CMV, Syphilis, West Nile, and more — by Eurofins DPT (CLIA ID: 06D0717586); (2) 14-day sterility testing per USP <71>; (3) endotoxin testing <0.100 EU/mL; (4) Nanoparticle Tracking Analysis confirming 3.65×10¹¹ exosome particles/mL; and (5) 6-factor growth factor quantification by Ohio University Innovation Center. A signed Certificate of Analysis ships on top of every box.
APEX offers B2B wholesale pricing to licensed medical partners. Pricing is based on volume and product type (APEX IV / WJ+ or APEX XO Exosomes). Because APEX is a turnkey partner program — including physician training, marketing support, consent documentation, and protocol guides — your investment includes far more than product alone. Contact us for current pricing.
Yes. APEX XO is an umbilical cord-derived exosome product available to licensed medical practices. APEX XO delivers 3.65×10¹¹ particles/mL verified by Nanoparticle Tracking Analysis, with mean particle diameter of 128.3 nm — within optimal therapeutic range. Endotoxin <0.05 EU/mL with 108% spike recovery. Stored at -20°C. Unlike exosome-only competitors, APEX also offers WJ+ which contains live MSCs alongside exosomes for the complete regenerative signal.
APEX is the only B2B stem cell supplier that: publishes per-lot growth factor concentrations in pg/mL; uses two independent testing institutions (Eurofins DPT + Ohio University); verifies exosome counts by NTA on every lot; operates its own clinical practice to validate protocols before distributing them to partners; and provides a complete turnkey system — training, marketing, consent documentation, and ongoing support. Competitors supply product only. APEX supplies the complete system.